Navigation Links
FDA Warns Against Use of Diarrhea Drug From El Salvador
Date:9/19/2012

WEDNESDAY, Sept. 19 (HealthDay News) -- Consumers should not use a drug product called Intestinomicina -- marketed as a treatment for infectious diarrhea and acute gastrointestinal infections -- because it contains an ingredient that can cause serious and potentially deadly problems, the U.S. Food and Drug Administration warns.

People who bought Intestinomicina should immediately stop taking it and consult with a health care provider, the FDA said in a safety alert issued Tuesday.

Intestinomicina, which is made in El Salvador, contains a prescription drug ingredient called chloramphenicol. Earlier this year, in July, oral forms of chloramphenicol were taken off the U.S. market due to the risk of serious health problems.

The most dangerous threat associated with oral chloramphenicol is bone marrow toxicity, which occurs when the body does not produce enough red blood cells, white blood cells and/or platelets, the FDA noted in a news release.

While some types of bone marrow toxicity are reversible, in certain rare cases it can lead to death. Those at greatest risk for serious injury or death are patients with anemia, low white or red blood cell count, or decreased blood platelets.

Intestinomicina's label also lists antibacterial ingredients including neomycin, which is an antibiotic often found in topical medications, and sulfonamides (sulfa drugs). Neomycin and sulfa drugs can cause a variety of reactions, ranging from rashes and hives to severe and life-threatening reactions, the FDA said.

In addition, Intestinomicina may interact with other medications people may be taking, the FDA pointed out in the news release.

Intestinomicina -- made by Laboratorios Lopez -- is sold in tablet and liquid form by international grocery stores in the United States that feature South and Central American specialty foods and products.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about diarrhea and its treatment.

-- Robert Preidt

SOURCE: U.S. Food and Drug Administration, news release, Sept. 18, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dont cut lifesaving ICDs during financial crisis, ESC warns
2. US risks losing out to Asia in medical research, U-M team warns
3. Extreme Heat Biggest Weather Killer, Expert Warns
4. CDC Warns of Another Emerging Tick-Borne Threat
5. The US Drug Watchdog Now Warns Time Could Run Out to Get Women Yaz or Yasmin Birth Control Pill Users Identified if they Suffered a Heart Attack Stroke or a Embolism
6. New device warns workers of high levels of airborne metals in minutes rather than weeks
7. FDA Warns of Fake Version of ADHD Drug Adderall
8. Immigrant women giving birth in Spain suffer great stress, a study warns
9. Vall d’Hebron, VHIO and SOLTI head up an international dream team against breast cancer
10. New gene offers hope for preventive medicine against fractures
11. Drug combination against NRAS-mutant melanoma discovered
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Warns Against Use of Diarrhea Drug From El Salvador 
(Date:7/23/2017)... ... July 24, 2017 , ... Three ... in Medicine (AAPM) 59th Annual Meeting & Exhibition, to be held in Denver, ... profession, hospital administrators and journalists can visit the AAPM Facebook page to watch ...
(Date:7/23/2017)... ... 23, 2017 , ... Better education to coaches and parents ... work today at the American Orthopaedic Society for Sports Medicine’ s ... to prospectively document the association between sports specialization and lower extremity injuries in ...
(Date:7/23/2017)... ... July 23, 2017 , ... Longtime Brevard County pain ... Melbourne, a practice owned by Physician Partners of America at 109 Silver Palm ... also is certified in pediatrics, emergency medicine and anesthesiology. , A longtime practitioner ...
(Date:7/22/2017)... ... 22, 2017 , ... More than 130,000 Anterior Cruciate Ligament ... pain medication after three months post-operatively. However, researchers presenting their work at the ... Ontario, Canada found that those patients who were filling opioid prescriptions prior to ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Wettstein ... to communities in the greater Denver region, is announcing a charity drive to ... very rare kind of epilepsy. , Until a few months ago, Dominik was ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... FREMONT, Calif. , July 13, 2017 RK ... (CA) Board of Pharmacy certification for its Fremont, ... chain support solutions in the Tri-Valley and San ... The City of Fremont , with its ... Logistics Group to provide such a powerful resource to the ...
(Date:7/11/2017)... WHIPPANY, N.J. , July 11, 2017  Bayer has ... across eight countries as part of its prestigious Bayer Hemophilia ... Children,s Hospital of Philadelphia and Uniformed ... are among the winners. Grant recipients were announced ... Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany ...
(Date:7/10/2017)... -- US medical equipment and supply demand is forecast to ... Medical Equipment & Supplies: United States , a ... in demand for medical services – driven in large ... by gains in disposable personal income – will boost ... will also drive sales as providers and patients seek ...
Breaking Medicine Technology: